{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:03:44Z","timestamp":1791288224696,"version":"4.3.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,3,21]],"date-time":"2010-03-21T00:00:00Z","timestamp":1269129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s12253-010-9254-x","type":"journal-article","created":{"date-parts":[[2010,3,20]],"date-time":"2010-03-20T19:16:26Z","timestamp":1269112586000},"page":"303-309","source":"Crossref","is-referenced-by-count":65,"title":["FOXP3+ Cell Density in Primary Tumor Has No Prognostic Impact in Patients with Cutaneous Malignant Melanoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Andrea","family":"Lad\u00e1nyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mohos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00e1ta","family":"Somlai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Liszkay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Gilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Fej\u0151s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Gaudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"T\u00edm\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,21]]},"reference":[{"key":"9254_CR1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00262-003-0479-3","volume":"53","author":"A Paschen","year":"2004","unstructured":"Paschen A, Eichm\u00fcller S, Schadendorf D (2004) Identification of tumor antigens and T-cell epitopes, and its clinical application. Cancer Immunol Immunother 53:196\u2013203","journal-title":"Cancer Immunol Immunother"},{"key":"9254_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0065-2776(08)60911-6","volume":"74","author":"FM Marincola","year":"2000","unstructured":"Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S (2000) Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 74:181\u2013273","journal-title":"Adv Immunol"},{"key":"9254_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","volume":"5","author":"W Zou","year":"2005","unstructured":"Zou W (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5:263\u2013274","journal-title":"Nat Rev Cancer"},{"key":"9254_CR4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00262-006-0194-y","volume":"56","author":"KL Knutson","year":"2007","unstructured":"Knutson KL, Disis ML, Salazar LG (2007) CD4 regulatory T cells in human cancer pathogenesis. Cancer Immunol Immunother 56:271\u2013285","journal-title":"Cancer Immunol Immunother"},{"key":"9254_CR5","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942\u2013949","journal-title":"Nat Med"},{"key":"9254_CR6","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1158\/1078-0432.CCR-06-0369","volume":"12","author":"N Hiraoka","year":"2006","unstructured":"Hiraoka N, Onozato K, Kosuge T, Hirohashi S (2006) Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12:5423\u20135434","journal-title":"Clin Cancer Res"},{"key":"9254_CR7","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","volume":"24","author":"GJ Bates","year":"2006","unstructured":"Bates GJ, Fox SB, Han C et al (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24:5373\u20135380","journal-title":"J Clin Oncol"},{"key":"9254_CR8","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1158\/1078-0432.CCR-06-2363","volume":"13","author":"N Kobayashi","year":"2007","unstructured":"Kobayashi N, Hiraoka N, Yamagami W et al (2007) FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 13:902\u2013911","journal-title":"Clin Cancer Res"},{"key":"9254_CR9","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1200\/JCO.2006.09.4565","volume":"25","author":"Q Gao","year":"2007","unstructured":"Gao Q, Qiu S-J, Fan J et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25:2586\u20132593","journal-title":"J Clin Oncol"},{"key":"9254_CR10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/pros.20538","volume":"67","author":"SB Fox","year":"2007","unstructured":"Fox SB, Launchbury R, Bates GJ et al (2007) The number of regulatory T cells in prostate cancer is associated with the androgen receptor and hypoxia-inducible factor (HIF)-2\u03b1 but not HIF-1\u03b1. Prostate 67:623\u2013629","journal-title":"Prostate"},{"key":"9254_CR11","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1158\/1078-0432.CCR-06-2139","volume":"13","author":"SA Siddiqui","year":"2007","unstructured":"Siddiqui SA, Frigola X, Bonne-Annee S et al (2007) Tumor-infiltrating Foxp3\u2212CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 13:2075\u20132081","journal-title":"Clin Cancer Res"},{"key":"9254_CR12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/1078-0432.CCR-05-1886","volume":"12","author":"C Badoual","year":"2006","unstructured":"Badoual C, Hans S, Rodriguez J et al (2006) Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancer. Clin Cancer Res 12:465\u2013472","journal-title":"Clin Cancer Res"},{"key":"9254_CR13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","volume":"27","author":"P Salama","year":"2009","unstructured":"Salama P, Phillips M, Grieu F et al (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27:186\u2013192","journal-title":"J Clin Oncol"},{"key":"9254_CR14","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1158\/1078-0432.CCR-04-1869","volume":"11","author":"T \u00c1lvaro","year":"2005","unstructured":"\u00c1lvaro T, Lejeune M, Salvad\u00f3 MT et al (2005) Outcome in Hodgkin\u2019s lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 11:1467\u20131473","journal-title":"Clin Cancer Res"},{"key":"9254_CR15","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","volume":"108","author":"J Carreras","year":"2006","unstructured":"Carreras J, Lopez-Guillermo A, Fox BC et al (2006) High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 108:2957\u20132964","journal-title":"Blood"},{"key":"9254_CR16","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","volume":"21","author":"LM Gjerdrum","year":"2007","unstructured":"Gjerdrum LM, Woetmann A, Odum N et al (2007) FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia 21:2512\u20132518","journal-title":"Leukemia"},{"key":"9254_CR17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10428190701824536","volume":"49","author":"NR Lee","year":"2008","unstructured":"Lee NR, Song EK, Jang KY et al (2008) Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis. Leuk Lymphoma 49:247\u2013256","journal-title":"Leuk Lymphoma"},{"key":"9254_CR18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2133.2007.08057.x","volume":"157","author":"V Mourmouras","year":"2007","unstructured":"Mourmouras V, Fimiani M, Rubegni P et al (2007) Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases. Br J Dermatopathol 157:531\u2013539","journal-title":"Br J Dermatopathol"},{"key":"9254_CR19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.jid.5701046","volume":"128","author":"G Panfilis De","year":"2008","unstructured":"De Panfilis G, Campanini N, Santini M et al (2008) Phase- and stage-related proportions of T cells bearing the transcription factor FOXP3 infiltrate primary melanoma. J Invest Dermatol 128:676\u2013684","journal-title":"J Invest Dermatol"},{"key":"9254_CR20","first-page":"1115","volume":"18","author":"C Miracco","year":"2007","unstructured":"Miracco C, Mourmouras V, Biagioli M et al (2007) Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma. Oncol Rep 18:1115\u20131122","journal-title":"Oncol Rep"},{"key":"9254_CR21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00262-007-0353-9","volume":"57","author":"F Hillen","year":"2008","unstructured":"Hillen F, Baeten CIM, van de Winkel A et al (2008) Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma. Cancer Immunol Immunother 57:97\u2013106","journal-title":"Cancer Immunol Immunother"},{"key":"9254_CR22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1158\/1078-0432.CCR-1161-03","volume":"10","author":"A Lad\u00e1nyi","year":"2004","unstructured":"Lad\u00e1nyi A, Somlai B, Gilde K et al (2004) T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma. Clin Cancer Res 10:521\u2013530","journal-title":"Clin Cancer Res"},{"key":"9254_CR23","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00262-007-0286-3","volume":"56","author":"A Lad\u00e1nyi","year":"2007","unstructured":"Lad\u00e1nyi A, Kiss J, Somlai B et al (2007) Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol Immunother 56:1459\u20131469","journal-title":"Cancer Immunol Immunother"},{"key":"9254_CR24","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong S-J et al (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635\u20133648","journal-title":"J Clin Oncol"},{"key":"9254_CR25","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1158\/0008-5472.CAN-07-5664","volume":"68","author":"LM Ebert","year":"2008","unstructured":"Ebert LM, Tan BS, Browning J et al (2008) The regulatory T cell-associated transcription factor FOXP3 is expressed by tumor cells. Cancer Res 68:3001\u20133009","journal-title":"Cancer Res"},{"key":"9254_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.humimm.2004.05.016","volume":"66","author":"ME Morgan","year":"2005","unstructured":"Morgan ME, van Bilsen JH, Bakker AM et al (2005) Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 66:13\u201320","journal-title":"Hum Immunol"},{"key":"9254_CR27","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/eji.200526189","volume":"35","author":"G Roncador","year":"2005","unstructured":"Roncador G, Brown PJ, Maestre L et al (2005) Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 35:1681\u20131691","journal-title":"Eur J Immunol"},{"key":"9254_CR28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","volume":"37","author":"J Wang","year":"2007","unstructured":"Wang J, Ioan-Facsinay A, van der Voort EI et al (2007) Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 37:129\u2013138","journal-title":"Eur J Immunol"},{"key":"9254_CR29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330\u2013336","journal-title":"Nat Immunol"},{"key":"9254_CR30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.immuni.2005.01.016","volume":"22","author":"JD Fontenot","year":"2005","unstructured":"Fontenot JD, Rasmussen JP, Williams LM et al (2005) Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22:329\u2013341","journal-title":"Immunity"},{"key":"9254_CR31","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057\u20131061","journal-title":"Science"},{"key":"9254_CR32","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/intimm\/dxh165","volume":"16","author":"H Yagi","year":"2004","unstructured":"Yagi H, Nomura T, Nakamura K et al (2004) Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 16:1643\u20131656","journal-title":"Int Immunol"},{"key":"9254_CR33","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1172\/JCI19441","volume":"112","author":"MR Walker","year":"2003","unstructured":"Walker MR, Kasprowicz DJ, Gersuk VH et al (2003) Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25\u2212 T cells. J Clin Invest 112:1437\u20131443","journal-title":"J Clin Invest"},{"key":"9254_CR34","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1172\/JCI24685","volume":"115","author":"SE Allan","year":"2005","unstructured":"Allan SE, Passerini L, Bacchetta R et al (2005) The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 115:3276\u20133284","journal-title":"J Clin Invest"},{"key":"9254_CR35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxm014","volume":"19","author":"SE Allan","year":"2007","unstructured":"Allan SE, Crome SQ, Crellin NK et al (2007) Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19:345\u2013354","journal-title":"Int Immunol"},{"key":"9254_CR36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.immunol.24.021605.090547","volume":"24","author":"SF Ziegler","year":"2006","unstructured":"Ziegler SF (2006) FOXP3: of mice and men. Annu Rev Immunol 24:209\u2013226","journal-title":"Annu Rev Immunol"},{"key":"9254_CR37","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1158\/0008-5472.CAN-08-3804","volume":"69","author":"I Kryczek","year":"2009","unstructured":"Kryczek I, Liu R, Wang G et al (2009) FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Res 69:3995\u20134000","journal-title":"Cancer Res"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-010-9254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-010-9254-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-010-9254-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T06:39:13Z","timestamp":1559457553000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-010-9254-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,21]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9254"],"URL":"https:\/\/doi.org\/10.1007\/s12253-010-9254-x","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,21]]}}}